Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Patient Information Leaflet last updated on the eMC: 27/09/2011
PIL Restandol Testocaps 40 mg capsule, soft

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 27/09/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 17/02/2010 and displayed until 27/09/2011
Reasons for adding or updating:
  • Correction of spelling/typing errors
  • Change to side-effects
Updated on 05/02/2010 and displayed until 17/02/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 30/06/2009 and displayed until 05/02/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 10/04/2008 and displayed until 30/06/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 29/02/2008 and displayed until 10/04/2008
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to appearance of the medicine
  • Change to packaging
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
  • Change to how to administer the medicine
  • Change of product licence name
Updated on 28/01/2002 and displayed until 29/02/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   testosterone undecanoate